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Abstract
Development of the vertebrate forebrain and craniofacial structures are intimately linked processes, the coordinated growth
of these tissues being required to ensure normal head formation. In this study, we identify five small subsets of progenitors
expressing the transcription factor dbx1 in the cephalic region of developing mouse embryos at E8.5. Using genetic tracing
we show that dbx1-expressing cells and their progeny have a modest contribution to the forebrain and face tissues.
However, their genetic ablation triggers extensive and non cell-autonomous apoptosis as well as a decrease in proliferation
in surrounding tissues, resulting in the progressive loss of most of the forebrain and frontonasal structures. Targeted
ablation of the different subsets reveals that the very first dbx1-expressing progenitors are critically required for the survival
of anterior neural tissues, the production and/or migration of cephalic neural crest cells and, ultimately, forebrain formation.
In addition, we find that the other subsets, generated at slightly later stages, each play a specific function during head
development and that their coordinated activity is required for accurate craniofacial morphogenesis. Our results
demonstrate that dbx1-expressing cells have a unique function during head development, notably by controlling cell
survival in a non cell-autonomous manner.
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Introduction
Building the vertebrate head relies on complex developmental
programs involving molecular cross-talks between multiple cell
types belonging to the three germ layers [1]. Within the
developing brain, the acquisition of positional identity relies on
the formation of morphogen gradients, whose combination leads
to the nested expression of transcription factors, allowing sharp
boundaries between compartments and morphological subdivi-
sions of the developing brain to be formed [2]. Craniofacial
structures develop in close proximity with the brain, and the same
signalling molecules, namely Fgfs, Wnts, BMPs and Shh, are
involved in both brain and face morphogenesis [3,4]. However,
patterning information is not exclusively mediated by morphogens
passively diffusing from focal sources. For example, increasing
evidence supports the hypothesis of alternative mechanisms
involving the migration of signalling cells over long distances
during cerebral cortex development [5].
Cephalic neural crest cells (CNCCs) are key players in
vertebrate head development. They originate from the boundary
between the surface ectoderm and neural plate and undergo
epithelial-mesenchymal transformation to acquire a migratory
phenotype. CNCCs generated at mesencephalic and diencephalic
levels invade mainly the facial mesenchyme that will later give rise
to the frontonasal structures, whereas CNCCs of rhombencephalic
origin populate the branchial arches [6]. Genetic tracing
experiments in mice [7] and chick-quail chimeras [8] demonstrat-
ed that most of the craniofacial tissues, including the entire facial
skeleton, derive from CNCCs. In addition to their direct
contribution, CNCCs were proposed to convey patterning
information: in avian embryos, interspecies graft experiments
demonstrated that CNCCs-derived signals regulate beak morpho-
genesis [9]. CNCCs were also shown to control brain patterning in
chick embryos. Notably, ablation and electroporation experiments
revealed that CNCCs migration into the facial mesenchyme and
local secretion of BMP-antagonists is required to maintain fgf8
expression in the forebrain [10,11]. On top of their function in
patterning neural tissues, CNCCs were proposed to control cell
survival [12] as well as neural tube closure [13].
In mice, by contrast with chicks, little is known about the
possible interactions between the cranial mesenchyme and the
forebrain during development. In addition, evidence indicating
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that CNCCs are a source of signals involved in forebrain
development is presently lacking.
Dbx1 is a homeodomain transcription factor previously shown
to be expressed from E9.5 by restricted pools of progenitors in the
central nervous system [14,15]. Work performed in our laboratory
indicated that, in the forebrain, cells deriving from these
progenitors, born from E10.5 on, often share a migratory
behaviour and a signalling function [16–18]. In this study, we
identify five discrete subsets of dbx1-expressing cells in cephalic
regions at early stages (E8.25–E8.75) of mouse development. We
use a genetic ablation strategy to test the function of each of these
subsets and reveal their relative involvement in forebrain and face
development. We show by genetic tracing that the earliest dbx1-
expressing cells generate a subpopulation of CNCCs which play a
crucial role in head development by controlling proliferation and
survival in neural and non-neural head tissues.
Methods
Animals
All animals used in this study were handled according to
national regulations (approval #5096 from the French Ministry of
Research on the use of genetically modified animals) and approved
by the Veterinary Services of Paris (authorization to perform
experimentation on vertebrate animals #75-1454). Genetic
ablation of dbx1-expressing cells was achieved by conditional
expression of the diphtheria toxin A fragment (DTA), crossing
Dbx1IRES-loxP-Stop-loxP-DTA mice [16] (hereafter referred to as
Dbx1DTA) with various Cre recombinase expressing strains.
PGK:Cre animals [19] express Cre in the germ line, therefore
allowing complete ablation of all dbx1-expressing cells. Targeted
ablations of the different dbx1-expressing populations were
achieved using the Foxg1Cre [20], Wnt1:Cre [21], Nkx2.1:Cre [22]
and Nestin:Cre [23] lines. In order to perform genetic tracing of
dbx1-expressing cells, we crossed Dbx1IRES-Cre [16] (referred to as
Dbx1Cre) and ROSA26loxP-Stop-loxP-YFP [24] (referred to as R26YFP)
mice. In Dbx1Cre;R26YFP embryos, Cre-mediated recombination
occurs at the ROSA26 locus in every cell expressing dbx1, leading to
a permanent and irreversible expression of YFP.
Animals and embryos were genotyped by PCR using the
appropriate specific primers and DNA extracted from the tail or
yolk sack (for E8.5 and E9.5 embryos) as a template. At least three
embryos of each genotype were analysed for each embryonic day.
Embryo processing
For staging of the embryos, midday of the vaginal plug was
considered as embryonic day 0.5 (E0.5). To stage E8.5 and E9.5
embryos more precisely, the somites were counted. Subtle
variations in the size and morphology of embryos displaying the
same number of somites were observed. Thus, we reasonably
estimate that counting the somite for staging is accurate with a
margin of error of 1ss. All embryos were collected and dissected in
cold PBS and immediately fixed by immersion in 4% parafor-
maldehyde in 0.12 M phosphate buffer (PB) pH 7.2 at 4uC.
Fixation duration was determined depending on the subsequent
use of the embryos (see below). The neural tubes of E9.5 and
E12.5 embryos were opened at the level of the rhombencephalon.
E8.5, E9.5 and E12.5 embryos subjected to immunostaining
were fixed for 40–60 min, 60–90 min and 2 h, respectively. They
were cryoprotected overnight in 10% sucrose in PB, embedded in
a solution of 7.5% gelatine and 10% sucrose in PB, and frozen by
immersion in isopentane cooled at 255uC. 20 mm thick cryostat
sections were then obtained and collected on Superfrost Ultraplus
slides (Menzell-Glasser).
Embryos used for in situ hybridisation, TUNEL or Nissl staining
were fixed $4 h at 4uC. For storage, E8.5 and E9.5 specimens
were dehydrated and stored in methanol whereas E12.5 heads
were embedded in gelatine/sucrose.
Immunostaining
The following primary antibodies were used: chick anti-GFP
(AvesLab; 1:2000), rabbit anti-AP2a (Santa Cruz; H-79; 1:100),
rabbit anti-PH3 (Upstate; 1:500) and rabbit anti-activated
Caspase-3 (Cell Signalling; 5A1; 1:800). For fluorescent staining,
secondary antibodies were purchased from Jackson Immunor-
esearch and slides were mounted in Vectashield with DAPI
(Biovalley). In some cases, biotinylated secondary antibodies were
used (Jackson Immunoresearch) and revealed using the Vectastain
ABC kit (Vector) and diaminobenzidine (Sigma) as a substrate.
Slides were then mounted in Mowiol.
TUNEL
Whole mount TUNEL was performed using the Apoptag
Peroxidase in situ Apoptosis Detection kit (Millipore) according to
the manufacturer’s instructions. Briefly, embryos were rehydrated
and digested with 10 mg/mL proteinase K for 3 min. They were
incubated with terminal deoxynucleotidyl transferase for 1 h at
37uC. The reaction was revealed using an alkaline phosphatase-
conjugated anti-digoxigenin antibody (Roche) and NBT/BCIP
(Roche) as a substrate.
In situ Hybridisation
Digoxigenin-labelled riboprobes for dbx1, dlx1, emx2, foxg1, ngn2,
otx1, pax6, six3, sox10 and wnt1 were synthesised with T3 or T7
RNA polymerases (Roche) using the Dig-RNA labelling mix
(Roche) and 1 mg of linearised DNA as a template. In situ
hybridisation on cryosections was performed as previously
described [25]. For whole-mount staining, embryos were rehy-
drated, post-fixed in 4% paraformaldehyde, 0.2% glutaraldehyde
in PBS, permeabilised in 1%SDS, 1%NP-40, 0.5% deoxycholate,
150 mM NaCl, 50 mM Tris pH 8, 1 mM EDTA and hybridised
in a buffer containing 50% formamide, 56 SSC, 2% BBR, 2%
SDS, 250 mg/mL yeast RNA, 100 mg/mL heparin and the probe
(1:50 dilution).
Images acquisition
Embryos stained by whole-mount in situ hybridisation or
TUNEL were incubated in 80% glycerol, 20% PBS and pictures
acquired using a Zeiss Axiocam HRc color camera coupled to a
Leica MZ FLIII stereomicroscope. Cryosections stained by Nissl,
in situ hybridization or DAB immunohistochemistry were acquired
using a Zeiss Axiocam HRc color camera coupled to a Zeiss
Axiovert 200 microscope. Images of sections from E12.5 animals
are composite that were generated by the Zeiss Axiovision
software using Mosaix and Tiling functions to automatically
reconstruct one image from multiple fields of the same specimen.
Immunofluorescence stainings were acquired on a Leica TCS SP5
confocal microscope. All images of double-labelling correspond to
a single confocal plane; in the case of sections stained with a single
primary antibody, max projections of a 5–15 mm z-stack were
used.
Quantitative PCR
RNA preparation, reverse transcription and qPCR were
performed as previously described [18]. Briefly, wild-type embryos
were dissected in cold PBS. For 2ss and older embryos, only tissues
anterior to the preotic sulcus (which marks the boundary between
Dbx1-Expressing Cells Control Head Formation
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rhombomeres 2 and 3) were analysed. Several embryos of
matching ages were pooled and RNA extraction was performed
using the RNeasy Micro Kit (Qiagen) following the manufacturer’s
instructions. 100–300 ng of total RNA was used for cDNA
synthesis using the SuperScript VILO cDNA synthesis kit
(Invitrogen). Samples were prepared using an epMotion 5070
(Eppendorf) automated pipetting system and qPCR was per-
formed on a LightCycler 480 (Roche) using the LightCycler 480
SYBR green Master I (Roche) reaction mix. Dbx1 expression was
calculated relative to the ribosomal protein S17 mRNA as
previously described [18]. Experiments were performed at least
in triplicates.
Quantifications
Counting of the percentage of cells which are PH3+ in the
neural plate and mesenchyme of E8.5 embryos was performed
manually, using DAPI staining to identify individual cells. Only
tissues located at presumptive midbrain and forebrain levels were
taken into account. At least 1000 cells were counted for n= 3
control and 4 mutant embryos. The number of pyknotic nuclei per
section was manually counted following thresholding of the DAPI
staining to reveal the highest levels of fluorescence. Histograms
represent mean 6 sem. Significance was assessed using Student’s
t-test.
Counting of the percentage of Caspase-3+ cells which are YFP
positive/negative was performed manually. Only Caspase-3+ cells
which displayed a ‘‘normal’’ morphology (i. e. exhibiting a nuclear
and a cytoplasmic compartment) were taken into account, thus
excluding cell debris or cells that had reached advanced stages of
cell death. The neuroepithelium was separated in two regions, one
corresponding to the telencephalon (showing a high degree of
recombination in FoxG1Cre embryos) and one corresponding to the
mesencephalon and diencephalon (showing a high degree of
recombination in Wnt1:Cre embryos). A total of .200 cells from
two FoxG1Cre;R26YFP;Dbx1DTA embryos (at 12ss and 13ss) and three
Wnt1:Cre;R26YFP;Dbx1DTA embryos (at 8ss and 10ss) were analysed.
Results
Genetic ablation of dbx1-expressing cells results in severe
defects of forebrain and craniofacial structures
The Dbx1 transcription factor is expressed by restricted
populations of progenitors during central nervous system devel-
opment. In the forebrain, dbx1 expression is notably detected at
the septum, ventral pallium and preoptic area around E10.5–
E12.5 [14–16]. In order to better understand the function of the
various cell populations deriving from these progenitors, we have
developed a genetic strategy to perform their conditional ablation.
The use of the Dbx1loxP-stop-loxP-DTA mice [16] and the appropriate
Cre recombinase-expressing strain enables us to selectively
eliminate specific dbx1-expressing populations. We previously used
Nestin:Cre, Emx1:Cre, deltaNp73Cre and E1-Ngn2:Cre mice to target
Dbx1-derived subtypes generated between E10.5 and E12.5 [16–
18]. Consistent with the limited number of dbx1-expressing cells,
formation of the forebrain occurred in these mutants.
In this study, we performed the complete ablation of all dbx1-
expressing cells using the PGK:Cre line [19] in which recombina-
tion occurs ubiquitously at early stages (1–2 cells stage) of
development. Surprisingly, severe craniofacial and brain morpho-
genesis defects were observed in E12.5 PGK:Cre;Dbx1DTA (Fig. 1A,
B). Consistently, a similar phenotype has been observed using
another ubiquitous and early Cre-expressing line [26] to ablate all
dbx1-expressing cells (not shown).
Nissl staining performed on coronal and sagittal sections of
E12.5 PGK:Cre;Dbx1DTA embryos indicated that the neural tube
was opened at presumptive midbrain levels and aberrantly folded
in rostral regions (Fig. 1C, D, I, J). Frontonasal structures were
reduced in size and the nasal cavity was absent. The eyes, though
shifted medially and incorrectly oriented, were present and their
gross morphology conserved in ablated mutants (Fig. 1I, J). We
performed in situ hybridisation with emx2 and foxg1 riboprobes to
label telencephalic structures and found that these territories were
severely affected in the mutants, with only a small anterior
territory being emx2 and foxg1 positive (Fig. 1E–H). The absence of
olfactory epithelium, which normally expresses emx2 and foxg1, was
also confirmed in ablated mutants. The remaining telencephalic
Figure 1. Genetic ablation of dbx1-expressing cells results in
severe neural and craniofacial defects. Heads of wild-type (A) and
PGK:Cre;Dbx1DTA (B) E12.5 mouse embryos. Mutants are exencephalic
and display craniofacial malformations. (C–H) Alternate sagittal sections
of wild-type (C, E, G) and PGK:Cre;Dbx1DTA (D, F, H) E12.5 embryos
subjected to Nissl staining (C, D), emx2 (E, F) and foxg1 (G, H) in situ
hybridisation. (I–J) Coronal sections of wild-type (I) and PGK:Cre;Dbx1DTA
(J) E12.5 embryos stained by Nissl. The antero-posterior level at which
coronal sections were collected is indicated by yellow dashed lines in C
and D. The arrow in J points to the remaining telencephalon in ablated
embryos. (K–M) High magnification of these telencephalic tissues in
PGK:Cre;Dbx1DTA E12.5 embryo following emx2 (K), ngn2 (L) and dlx1 (M)
in situ hybridisation. Scale bars A: 500 mm, C, I: 400 mm, K: 200 mm.
doi:10.1371/journal.pone.0019367.g001
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tissue observed in PGK:Cre;Dbx1DTA embryos appeared as a small
vesicle (arrow in Fig. 1J) suggesting that neural tube closure did
occur at the most anterior levels. Indeed, we observed that the
dlx1+ domain is relatively segregated from the emx2+ and ngn2+
domains (Fig. 1K–M), indicating that dorso-ventral patterning was
maintained (ventral/dlx1+ domain is found dorsal because of the
folding of the remaining anterior nervous system; see Fig. 1D).
Taken together, these results indicate that the ablation of all
dbx1-expressing cells results in an absence of dorsal neural tube
closure at the midbrain level, a severe reduction in the size of the
forebrain, as well as strong defects of craniofacial structures.
Early dbx1-expressing cells are essential for forebrain and
facial development
In a previous study, we performed the ablation of cells expressing
the dbx1 gene in the central nervous system starting from E10.5 by
crossing Nestin:Cre and Dbx1loxP-stop-loxP-DTA animals [16]. E12.5
embryos resulting from such crosses displayed a much milder
phenotype than PGK:Cre;Dbx1DTA mutants, consisting in an obvious
reduction in the size of the mesencephalon and diencephalon (Fig.
S1A, B). Importantly, despite the strong reduction in the thickness of
the medial ganglionic eminence, the telencephalon of Nestin:-
Cre;Dbx1DTA appeared normal in size [16] (Fig. S1C, D) and
mutants were undistinguishable from wild-type littermates with
respect to craniofacial morphology (Fig. S1A, B). The major
difference of phenotype between Nestin:Cre and PGK:Cre ablated
mutants suggested that dbx1-expressing cells generated before E10.5
and/or outside of the central nervous system are essential for
midbrain, forebrain and craniofacial development.
We thus analysed earlier stages of development and found that
PGK:Cre;Dbx1DTA embryos were already severely affected at E9.5.
Dorsal midline closure failed to occur at midbrain and forebrain
levels and foxg1 expression was markedly reduced in ablated
mutants, indicating that the telencephalic primordium was strongly
reduced (Fig. 2A–D). Dorsal mesencephalic and posterior dience-
phalic territories, identified by wnt1 expression, appeared missing
whereas no obvious defects were observed in the rhombencephalon
(Fig. 2E, F). At 10–12ss (E8.75) mutant embryos were already
distinguished from wild-type littermates due to the failure in neural
tube closure. Around 4–6ss (E8.5), the mutants could also be
identified based on their morphology: measurements of the length of
the headfold between the pre-otic sulcus and the anterior limit of the
forebrain revealed a significant decrease in ablated mutants
compared to wild-type embryos (21% reduction; Fig. S2B). We
also measured a 14% reduction in the width of the neural plate at
the mesencephalic level of 2–4ss (E8.25) embryos (Fig. S2A).
We thus find that morphological defects in ablated mutants are
first seen at early somitic stages.
Early dbx1 expression pattern identifies several
progenitor subsets
Our observation that ablated mutants display measurable
defects from E8.25 were unexpected considering the initial report
that dbx1 expression only starts at E9.5 [15]. We therefore decided
to carefully re-examine the dbx1 expression pattern before E9.5
using in situ hybridisation.
With this technique, the earliest expression of dbx1 mRNA we
could detect was observed in 2ss embryos, in patches of cells
located in the lateral/dorsal neural plate at the midbrain level
(Fig. 3A–D, M). Dbx1 expression at this location (subsequently
referred to as EM, for ‘‘early midbrain’’) persisted at 3ss and 4ss
but was then downregulated by 6ss (Fig. 3E–F). At this stage dbx1
expression started in the ventral diencephalon (vDi, arrow in
Fig. 3E) and persisted later on (Fig. 3G–J). From 8ss (Fig. 3G–J),
dbx1 expression was found in the dorso-lateral diencephalon and
mesencephalon (dDM, arrow in Fig. 3G) with this domain
persisting and extending posteriorly at later stages (Fig. 3I). Of
note, the dDM expression domain overlaps with the midbrain area
in which dbx1 is expressed at 2–4ss. Between 10ss and 15ss, dbx1
expression was transiently found in the anterior neural ridge
(ANR, arrowhead in Fig. 3I), the anterior limit of the forebrain,
and in cells of the facial ectoderm (FE, arrow in Fig. 3I). Due to
their small size, these two domains were best visualised on coronal
sections (Fig. 3K, L). These results are summarised in Fig. 3Y.
We performed quantitative PCR (qPCR) experiments using RNA
extracted from embryos at stages ranging from E7.0 to 10ss (E8.75).
Consistent with in situ hybridisation experiments, we failed to detect
dbx1 mRNAs at E7.0 and E7.5 (Fig. 3O). Dbx1 expression was
detected at low levels in E8.0 extracts and markedly increased (by,5
fold) at 2ss (E8.25). Expression then subsequently increased ,2 fold
between 2ss and 8ss and,4 fold between 8ss and 10ss. These results
therefore confirm the data obtained by in situ hybridisation.
We thus conclude that dbx1 expression starts concomitantly to
the formation of the first somites and is highly dynamic. In
addition, we show for the first time that dbx1 is expressed outside of
the central nervous system.
Figure 2. Loss of midbrain and forebrain tissues in ablated
mutants. Side (A, B, E, F) and front (C, D) views of wild-type (A, C, E)
and PGK:Cre;Dbx1DTA (B, D, F) E9.5 embryos (18–19ss) subjected to foxg1
(A–D) and wnt1 (E, F) whole mount in situ hybridisation. Most of neural
tissues anterior to the midbrain-hindbrain boundary (arrow in F) are
missing in ablated mutants. Scale bar: 200 mm.
doi:10.1371/journal.pone.0019367.g002
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Figure 3. Dbx1 expression and tracing. (A–J) Dbx1 expression analysed by whole-mount in situ hybridisation. B and D are dorsal views of the
embryos presented in A and C respectively, rostral is up. F, H and J are frontal views of the embryos shown in E, G and I respectively. Antero-posterior
subdivisions of the neural plate/tube are indicated. Mb: midbrain, Fb: Forebrain, Mes: mesencephalon, Di: diencephalon, Tel: telencephalon. Arrows in
E, G and I point to the vDi, dDM and FE subsets respectively; the arrowhead in I shows the ANR subset. (K, L) Coronal sections through the forebrain of
a 12ss embryo showing dbx1 expression in the ANR (K) and facial ectoderm (L). (M) Coronal section collected at the midbrain level of a 3ss embryo
illustrating dbx1 mRNA expression; the neural plate is delineated by dashed lines. (N) Coronal section collected at the level of the midbrain of a 6ss
Dbx1Cre;R26YFP embryo and stained for YFP (green) and DAPI (blue). (O) Quantification of dbx1 expression by qPCR. Asterisks indicate stages at which
dbx1 could not be amplified. The relative expression values (normalised to 1 at 2ss and expressed in arbitrary units) are indicated on top of each bar
as mean 6 s.e.m. (P, Q) Coronal sections of a 20ss (E9.5) Dbx1Cre;R26YFP embryo at the level of the telencephalon (P) and di/mesencephalon (Q),
stained for YFP (green) and DAPI (blue). YFP is detected in regions that express dbx1 at earlier stages: ANR (red arrowhead in P), FE (white arrowheads
in P), vDi and dDM (red and white arrowheads in P respectively) but also in cells located in the head mesenchyme (arrows in P). (R–W) Examples of
YFP+ cells found in the head mesenchyme of Dbx1Cre;R26YFP embryos at 8ss (R–T) and 11ss (U–W) revealed by DAB immunostaining. Sections in R, S
and U were collected at telencephalic levels, T, V and W at diencephalic levels. Neural tissues, surface ectoderm and endoderm are surrounded by
black, blue and green dash lines respectively. (X) Coronal sections of a 8ss Dbx1Cre;R26YFP embryo immunostained for YFP (green) and the neural crest
cells marker AP2a (red); cell nuclei are stained by DAPI (blue). Some of the YFP+ cells found in the neural plate are AP2a2 (arrowhead in X1) whereas
Dbx1-Expressing Cells Control Head Formation
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Tracing of early dbx1-expressing populations
Although telencephalic and frontonasal tissues are severely
affected upon genetic ablation of all dbx1-expressing cells, we only
found little expression of dbx1 in theses structures. In order to test
whether tissues that form the telencephalon and face derive from
dbx1-expressing progenitors but no longer express dbx1 mRNA, we
used permanent tracing to follow the progeny of dbx1-expressing
cells. We analysed Dbx1Cre;R26YFP embryos between E8.0 and E9.5
using YFP immunostaining to visualise cells deriving from dbx1-
expressing progenitors. Consistent with expression data, we never
observed YFP+ cells at E8.0. YFP expression was first detected in
the mesencephalon at 6ss (Fig. 3N) with a pattern reminiscent of
dbx1 mRNA expression at 2–4ss (compare Fig. 3M and N). YFP+
cells were then found in the vDi around 9–10ss (shown at 11ss in
Fig. S3B) and in the dDM around 12–13ss (Fig. S3F and data not
shown). At E9.5 (20ss), YFP+ cells were detected in the ANR and
FE (arrowheads in Fig. 3P) as well as in the vDi and dDM
(Fig. 3Q). Thus, YFP expression at E8.5 and E9.5 in Dbx1Cre;R26-
YFP embryos recapitulates dbx1 expression as observed by ISH. We
found that the onset of YFP expression occurred,3–4ss later than
that of the dbx1 gene, indicating that the delay between mRNA
expression and recombination and subsequent accumulation of the
reporter protein spans around ,5–6 hours (at this stage, one
somite is formed every ,90 minutes [27]).
One noticeable exception to the similarity between YFP and dbx1
expression patterns was the presence of YFP+ cells in the head
mesenchyme (arrows in Fig. 3P and Fig. 3R–W). Importantly, we
never observed Dbx1 mRNA, protein, or LacZ expression in this
tissue (in dbx1LacZ/+ embryos, in which the lacZ gene has been inserted
at the first ATG of the dbx1 gene and allows to trace all Dbx1-derived
cells without delay due to the recombination [25]). Mesenchymal
Dbx1-derived cells were first found around 6–8ss, suggesting that they
derive from the EM population (at this stage, only EM-derived cells
are YFP+). At later stages, EM and dDM progenitor domains
partially overlap, making it difficult to determine whether the dDM
subset also contribute to these mesenchymal cells. Cephalic neural
crest cells (CNCCs) are known to be generated at early somitic stages
at the interface between the meso-diencephalic neural plate and
surface ectoderm and to subsequently delaminate to invade the facial
mesenchyme. We therefore tested the possibility that mesenchymal
cells deriving from dbx1-expressing progenitors are CNCCs by
performing double immunostaining for YFP and the transcription
factor AP2a (a marker of NCCs [28]) on cryosections of
Dbx1Cre;R26YFP embryos. We found that all YFP+ cells in the head
mesenchyme, but also some in the lateral neural plate, were AP2a+
(Fig. 3X), showing that EM (and possibly dDM) dbx1-expressing
progenitors generate CNCCs.
We therefore conclude that Dbx1-derived cells do not massively
contribute to some of the territories that are most affected in
ablated mutants, namely the forebrain and face, suggesting that
the defects observed are non cell-autonomous.
Genetic ablation of dbx1-expressing cells does not affect
antero-posterior patterning of the neural plate but
results in proliferation defects
In order to determine the mechanisms that were responsible for
the defects observed in PGK:Cre;Dbx1DTA embryos, we first tested
whether the specification of forebrain tissues occurs correctly in
ablated embryos. We analysed the expression of the neural
regionalisation markers emx2, otx1, pax6 and six3 in
PGK:Cre;Dbx1DTA and control embryos using in situ hybridisation.
Analyses were done at 5–6ss, when the initial regionalisation of the
neural plate in a hindbrain, midbrain and forebrain is achieved
and when the ablated phenotype is already detectable. At this
stage, in wild-type embryos, six3 is expressed in the most anterior
aspect of the neurectoderm (Fig. 4A), emx2 identifies the dorsal
telencephalic anlage (Fig. 4B), pax6 expression is found in the
forebrain and hindbrain (Fig. 4C), and otx1 is expressed in the
midbrain and forebrain (Fig. 4D). An identical expression pattern
was observed in PGK:Cre;Dbx1DTA embryos, although the antero-
posterior extent of the various domains appeared reduced
compared to wild-types (Fig. 4E–H), consistent with the smaller
YFP+ cells located at the most lateral aspect of the neural plate or in the mesenchyme (arrows in X1–X3) are AP2a
+. Images X1–X3 correspond to single
confocal planes. (Y) Schematic drawing of dbx1 expression pattern. Scale bars: A: 200 mm; K, M, N, R, X: 50 mm; P: 100 mm.
doi:10.1371/journal.pone.0019367.g003
Figure 4. Antero-posterior regionalisation and proliferation in
ablated mutants. (A–H) Whole-mount in situ hybridisation of 5 to 6ss
control (A–D) and PGK:Cre;Dbx1DTA (E–H) embryos using probes against
six3 (A, E), emx2 (B, F), pax6 (C, G) and otx1 (D, H). (I–J) Coronal sections
collected at the level of the midbrain of 5ss control (I) and
PGK:Cre;Dbx1DTA (J) embryos immunostained for phosphorylated
histone-3 (PH3, green) and DAPI (blue). (K–L) Higher magnification of
the DAPI staining, pyknotic nuclei are highly fluorescent. Quantifica-
tions (M, N) revealed a significant reduction in the number of PH3+ cells
in the neural plate, but not in the mesenchyme, of mutant compared to
controls (M) as well as a significant increase in the number of pyknotic
cells per section (N). * p,0.05 in M and p,0.02 in N; n = 3 controls and
4 mutant embryos (4 to 8ss). Scale bars: A: 200 mm; I: 50 mm.
doi:10.1371/journal.pone.0019367.g004
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size of mutants at this stage (see Fig. S2A, B). We therefore
concluded that anterior neural structures are correctly induced
and patterned in ablated mutants.
We also tested possible changes in the regulation of dbx1
expression upon ablation of dbx1-expressing cells. At all stages
analysed, we only detected very weak dbx1 expression, which, most
importantly, was systematically found in regions corresponding to
dbx1-expressing areas in controls (Fig. S2C, 8D and data not
shown), ruling out the possibility that the defects observed in
ablated mutant result from ectopic upregulation of dbx1 (and
hence, ectopic toxin production).
We then analysed proliferation using phospho-histone 3 (PH3)
immunostaining on 4 to 8ss embryos. Quantifications revealed a
mild (27%) but significant decrease in the percentage of PH3+ (i. e.
mitotic) cells in the neural plate of ablated mutants compared to
controls (Fig. 4I, J, M). By contrast, we found no significant
differences in the percentage of PH3+ cells in the head
mesenchyme. It therefore appears that proliferation in the neural
tube is reduced upon ablation of dbx1-expressing cells.
Interestingly, careful examination of DAPI staining on these
specimens revealed a ,10 fold increase in the number of pyknotic
nuclei compared to control littermates (Fig. 4K, L, N), suggesting
enhanced cell death occurred in ablated embryos.
Genetic ablation of dbx1-expressing cells triggers
extensive apoptosis
To test whether tissues were undergoing apoptosis in ablated
mutants, we performed whole-mount TUNEL staining. At E8.0,
consistent with the fact that dbx1 expression is just starting (not yet
detected by in situ hybridisation but found at low levels by qPCR),
both ablated and wild-type littermates displayed low levels of
apoptosis (Fig. S2D). At 2ss, increased apoptosis was found
throughout the neural plate (Fig. 5A–D), in the forebrain (Fig. 5E,
F) and midbrain (Fig. 5G, H), but not at spinal cord levels (Fig.
S2E). Of note, TUNEL staining was typically more pronounced in
the lateral aspect of the neural plate and at the junction with
surface ectoderm. At later stages (11–13ss), increased TUNEL-
staining was also observed in ablated mutants compared to wild-
types (Fig. 5I–L). Reminiscent of earlier stages, apoptotic cells were
mainly located in the dorsal and anterior regions of the neural tube
as well as in the surface ectoderm, especially at the level of the
forebrain (Fig. 5M, N).
Importantly, we found striking differences between the pattern
of dbx1 expression in wild type embryos and the distribution of
apoptotic cells in ablated animals. At 2–4ss, when dbx1 is expressed
in a patch of cells in the midbrain (EM subset), ablated mutants of
the same stage display apoptosis throughout the neural plate,
including the most anterior and lateral regions (compare Fig. 3D
and 5D). At 10–12ss, when four distinct dbx1-expressing
populations are identified in control embryos (vDi, dDM, ANR
and FE), PGK:Cre;Dbx1DTA littermates exhibit a continuous stripe
of TUNEL+ cells in the dorsal midbrain and forebrain (compare
Fig. 3I and 5J). Furthermore, the number of apoptotic cells
observed in the telencephalon of PGK:Cre;Dbx1DTA at 11–18ss
(Fig. 5J, L and data not shown) by far exceeded the one of Dbx1-
derived cells as indicated by genetic tracing in 20ss Dbx1Cre;R26YFP
embryos (Fig. 3P).
Figure 5. Increased apoptosis in ablated mutants. Whole-mount TUNEL staining of 2ss (A–D) and 11–13ss (I–L) control (A, C, I, K) and
PGK:Cre;Dbx1DTA (B, D, J, L) embryos. C and D are dorsal views of the embryos shown in A and B respectively. (E–H) are cryosections of the embryos
shown in A and B at the level of the forebrain (E, F) and midbrain (G, H) as indicated by dashed lines in C and D. K and L are front views of the
embryos shown in I and J respectively. M and N are cryosections collected at the level of the diencephalon of these embryos as indicated by dashed
lines in I and J. Neural tissues are surrounded by a dashed line for better visualisation. Scale bars: A, I: 200 mm; E, M: 100 mm.
doi:10.1371/journal.pone.0019367.g005
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Together, these results indicate that the apoptosis observed in
ablated mutants starts almost concomitantly to the onset of dbx1
expression and, in a large extent, occurs in regions that neither
express dbx1 nor derive from Dbx1-expressing progenitors. They
also suggest that dbx1-expressing cells present at 2–4ss promote the
survival of neighbouring tissues in a non cell-autonomous manner.
Specific requirements of the dbx1-expressing
subpopulations for forebrain and head development
In order to directly test the function of the different dbx1-
expressing subsets in forebrain and head development, we
attempted to perform their targeted ablation. To this end, we
used Nkx2.1:Cre [22], Wnt1:Cre [21] and Foxg1Cre [20] mouse lines
that we crossed with Dbx1loxP-stop-loxP-DTA animals.
We first analysed the pattern of recombination by crossing these
Cre-expressing mice with ROSA26loxP-stop-loxP-YFP reporters and
compared it to the distribution of Dbx1-derived cells at E8.5. The
Nkx2.1:Cre line allowed recombination in a domain encompassing
the vDi dbx1-expressing population (Fig. S3A, B). We confirmed
effective ablation of this subset in Nkx2.1:Cre;Dbx1DTA embryos by
analysing dbx1 expression at E9.5 (19ss; Fig. S3C, D). With the
Wnt1:Cre line, recombination occurred in the dorsal mesenceph-
alon and diencephalon, overlapping with the dDM dbx1-
expressing population (Fig. S3E, F). Dbx1 expression at E9.5
(19ss) in Wnt1:Cre;Dbx1DTA embryo indicated a complete ablation
of the dDM subset (Fig. S3G, H). The Foxg1Cre line drove
recombination in the most anterior part of the neural tube as well
as the surface ectoderm at stages preceding the onset of dbx1
expression in the ANR and FE (Fig. S3I). Dbx1 in situ hybridisation
on Foxg1Cre;Dbx1DTA 14ss embryos confirmed the efficient ablation
of both the ANR and FE subsets (Fig. S3O–T). In addition, the
Foxg1Cre line allowed a salt-and-pepper recombination in the
neural tube and mesenchyme all along the antero-posterior axis
(Fig. S3J), suggesting that at least some dbx1-expressing cells from
the vDi and dDM subsets are also targeted. However, the extent of
such an ectopic recombination did not appear to significantly
affect these populations as revealed by dbx1 in situ hybridisation on
Foxg1Cre;Dbx1DTA E9.5 (20ss) embryos (Fig. S3K, L).
At last, we found that in both the Foxg1Cre and Wnt1:Cre lines,
some recombination occurs at early somitic stages in the area of
dbx1 expression in the midbrain (Fig. S3M, N; compare with
Fig. 3N), suggesting that the EM subset is partially targeted by
these two lines. It is also worth noting that CNCCs in the head
mesenchyme were targeted by the Wnt1:Cre line (Fig. S3E, N; as
previously described [21]).
In summary, the Nkx2.1:Cre line targets the vDi subset, the
Foxg1Cre line partially targets the EM, vDi and dDM subsets and
completely targets the ANR and FE subsets, and the Wnt1:Cre line
partially targets the EM subsets and completely targets the dDM
subset (Table 1).
We then analysed apoptosis in the various selectively ablated
mutants. Interestingly, Nkx2.1:Cre;Dbx1DTA embryos displayed the
same low levels of apoptosis than their wild-type counterparts
between 3ss and 15ss (Fig. 6A, B, E, F, I, J, M, N and data not
shown). We therefore concluded that the vDi dbx1-expressing
population is dispensable for the survival of anterior tissues. Both
Foxg1Cre;Dbx1DTA embryos (Fig. 6C, G) and Wnt1:Cre;Dbx1DTA
(Fig. 6D, H) showed increased apoptosis from 3–4ss compared to
controls (Fig. 6A, E), but in an extent that did not match the levels
observed in PGK:Cre;Dbx1DTA mutants (Fig. 5D, H). Such an
observation not only confirms that the EM subset is essential for
the survival of the neural plate cells, but also that it is partially (but
not completely) targeted by the Wnt1:Cre and Foxg1Cre lines. At 8–
9ss, increased apoptosis was observed in Wnt1:Cre;Dbx1DTA and
Foxg1Cre;Dbx1DTA embryos (Fig. 6I, K–M, O, P). With the Foxg1Cre
line apoptotic cells were typically sparse along the antero-posterior
and dorso-ventral axis of the forebrain and midbrain; many were
also found in the facial surface ectoderm (Fig. 6K, O). By contrast,
using theWnt1:Cre line, increased apoptosis was most prominent in
the dorsal midbrain (Fig. 6L, P).
Each targeted ablation therefore yields a specific pattern of
apoptosis, and none of them recapitulates the complete ablation.
In order to precisely determine which cells undergo apoptosis in
the different ablated embryos, we generated mice bearing both the
Dbx1loxP-stop-loxP-DTA and the ROSA26loxP-stop-loxP-YFP alleles and
mated them with Cre-expressing lines. We performed immuno-
staining for activated Caspase-3 and YFP on embryos resulting
from such crosses to reveal on the same specimen apoptotic and
recombined cells respectively. When using the Nkx2.1:Cre line, we
found Caspase-3+ cells in the vDi, with most of them also being
YFP+ (arrows in Fig. 6Q), showing that these cells died because
they were located in the recombination domain and expressed
dbx1 (and therefore DTA). When recombination was driven using
the Foxg1Cre strain, we observed increased apoptosis (similar to
TUNEL staining) and, interestingly, we counted that 163 out of
185 Caspase-3+ cells found in the mesencephalon and dienceph-
alon were YFP2 (i. e. not recombined; arrowheads in Fig. 6R and
Fig. S4). Similarly, with the Wnt1:Cre line, we counted that 69 out
of 81 apoptotic cells found in the forebrain region were not
recombined (arrowheads in Fig. 6S and Fig. S4), ruling out the
possibility that they died because of DTA expression. Control
embryos that did not express Cre recombinase displayed very low
levels of Caspase-3 staining (Fig. 6T). Taken together, these data
show that a significant part of the apoptosis observed in ablated
mutants is non cell-autonomous as previously suggested from the
analysis of PGK:Cre;Dbx1DTA embryos.
In addition to cell survival defects, we found that Wnt1:Cre
ablated embryos display a number of forebrain patterning defects.
Thus, around 8ss, we observed a dorsal and medial expansion of
the foxg1 expression domain (Fig. S5A–D) associated with a
posterior shift in the dorsal limit of the emx2 expression domain
(Fig. S5E–H). Since the Wnt1:Cre line does not drive recombina-
tion in the forebrain, we believe that these defects are strong
evidences in favour of a non cell-autonomous function of the
dorsal midbrain on forebrain patterning.
Early midbrain dbx1-expressing cells play a crucial role in
forebrain formation
When we examined the outcome of targeted ablations at
E12.5, we found that each mutant exhibited a mild facial
phenotype (Fig. 7A–D). Importantly, all three single mutants
Table 1. Extent by which each dbx1-expressing subset is
targeted by Cre-mediated recombination using the different
mouse lines.
Stage 2–4ss 6ssR 8ssR 10–15ss
Population EM vDi dDM ANR FE
Nkx2.1:Cre - Complete - - -
Foxg1Cre Partial Partial Partial Complete Complete
Wnt1:Cre Partial - Complete - -
Triple-Cre Partial Complete Complete Complete Complete
PGK:Cre Complete Complete Complete Complete Complete
doi:10.1371/journal.pone.0019367.t001
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formed a forebrain that was near normal in size, although its
patterning was affected (Fig. 7E–H and data not shown). Thus,
each targeted ablation results in a specific phenotype and none of
them recapitulate the complete ablation. This could either be
explained by a cooperative activity of different subsets, or by the
fact that the EM subset is not completely ablated in any of the
single mutants.
To discriminate between these two possibilities, we generated
Foxg1Cre;Nkx2.1:Cre; Wnt1:Cre (referred to as Triple-Cre) animals. We
first analysed Triple-Cre;Dbx1DTA embryos at E12.5 and found that
these animals exhibit craniofacial abnormalities similar to
PGK:Cre;Dbx1DTA embryos (Fig. 8A): the nasal cavity was absent
and the eyes were shifted medially in both mutants. However,
Triple-Cre;Dbx1DTA mutants vastly differ from PGK:Cre;Dbx1DTA
regarding brain development since the latter almost completely
lacked a forebrain at this stage while the former formed a forebrain
that was near normal in size (Fig. 8A, B). We therefore conclude
that the cumulative contribution of dbx1-expressing cells targeted
by both PGK:Cre and Triple:Cre lines (i.e. vDi, dDM, ANR and FE
subsets) is required for accurate craniofacial morphogenesis.
Conversely, dbx1-expressing cells that are targeted in PGK:Cre
but not in Triple-Cre ablated mutants (i.e. belonging to the ME
subset) are absolutely critical for forebrain formation.
In situ hybridisation for dbx1 at 4ss confirmed that the EM subset
is mostly spared in Triple-Cre;Dbx1DTA mutants (Fig. 8E). Although
dbx1 staining was decreased compared to control embryos, it was
much higher than in PGK:Cre;Dbx1DTA mutants, which only display
very few dbx1+ cells (Fig. 8C–E). We then performed TUNEL
staining and found that Triple-Cre;Dbx1DTA embryos display
increased apoptosis at 4ss compared to controls and single
ablations, but were not as severely affected as PGK:Cre;Dbx1DTA
embryos (Fig. 8F–K; see also Fig. 6B–D). Consistently, 4ss Triple-
Figure 6. Apoptosis upon targeted ablations. Whole-mount TUNEL staining of 3 to 4ss (A–D) and 8 to 9ss (I–L) control (A, I), Nkx2.1:Cre;Dbx1DTA
(B, J), Foxg1Cre;Dbx1DTA (C, K) and Wnt1:Cre;Dbx1DTA (D, L) embryos. E–H and M–P are cryosections of the embryos shown in A–D and I–L collected at
the level indicated by a dashed line. Neural tissues are surrounded by a dashed line for better visualisation. (Q–T) Immunostaining for activated
Caspase-3 (red), YFP (green) and DAPI (blue) on coronal cryosections of Nkx2.1:Cre;R26YFP;Dbx1DTA (Q), Foxg1Cre;R26YFP;Dbx1DTA (R),
Wnt1:Cre;R26YFP;Dbx1DTA (S) and control (T) embryos. Images in Q–T correspond to a single confocal plane. Arrows point to Caspase-3+/YFP+ cells,
arrowheads indicate Caspase-3+/YFP2 cells. Scale bars: A, I: 200 mm; E, M, Q, R: 100 mm; S, T: 50 mm.
doi:10.1371/journal.pone.0019367.g006
Dbx1-Expressing Cells Control Head Formation
PLoS ONE | www.plosone.org 9 April 2011 | Volume 6 | Issue 4 | e19367
Cre ablated mutants were more similar in size to their wild-type
counterparts than to PGK:Cre;Dbx1DTA embryos (Fig. 8C–H).
Since tracing experiments showed that the EM subset generates
CNCCs (Fig. 3X), we analysed CNCCs production in Triple-Cre
and PGK:Cre ablated mutants by in situ hybridisation for sox10, a
marker of NCCs [29]. At 4ss, when CNCCs are mainly
premigratory, PGK:Cre;Dbx1DTA embryos displayed a strong
reduction in sox10 staining whereas Triple-Cre;Dbx1DTA embryos
appeared significantly less affected (Fig. 8L–N). Similarly, at 8ss,
when CNCCs have invaded the cephalic mesenchyme in wild-type
embryos, PGK:Cre;Dbx1DTA counterparts were almost devoid of
sox10+ cells, whereas Triple-Cre;Dbx1DTA embryos were only mildly
affected (Fig. 8O–Q). By contrast, all three genotypes showed
similar strong staining in the branchial arch, which is mainly
invaded by rhombencephalic NCCs. These results show that the
severity of the forebrain phenotype, but not of the craniofacial
phenotype, correlate with the loss of CNCCs.
Taken together, our results suggest that a small number of early-
born dbx1-expressing cells and their CNCCs progeny have a
unique function during early steps of forebrain development by
promoting the survival and proliferation of neighbouring tissues in
a non cell-autonomous manner.
Discussion
In this study, we show that Dbx1-derived cells are essential for
forebrain and craniofacial development in mice. We have
identified five restricted dbx1-expressing subsets in the head at
early (E8.25–E8.75) developmental stages (EM, vDi, dDM, ANR
and FE). Complete genetic ablation of these cells results in
extensive and non cell-autonomous apoptosis as well as decreased
proliferation in tissues that will later give rise to the midbrain,
forebrain and face, leading to dramatic defects in head
morphogenesis. Careful analysis of the dynamics of dbx1
expression in wild-types and apoptosis in ablated mutants
indicated that the EM subset, which generates a small subpopu-
lation of CNCCs, is crucial to maintain the survival of
neighbouring tissues. In addition, targeted and combinatorial
ablations of the different subsets, using mutants carrying multiple
Cre-expressing transgenes, revealed that the vDi, dDM, ANR and
FE are collectively required to ensure accurate craniofacial
morphogenesis, whereas the EM is necessary for forebrain
formation.
Distinct contribution of Dbx1-derived cells to head
development
Dbx1 was previously reported to be expressed from E9.5 in the
mouse brain [14,15]. We now show that five distinct subsets of
dbx1-expressing cells can be identified at earlier stages (E8.25–
E8.75), including one in the facial ectoderm. This study is the first
to describe that dbx1 expression is not confined to the central
nervous system, as previously reported [15]. Unlike other
vertebrates [30] however, we did not find dbx1 expression in the
anterior axial mesendoderm of mouse embryos.
One of our most striking findings is that the presence or absence
of a limited number of cells from the Dbx1 lineage can have
profound consequences on brain and face morphogenesis. Thus,
PGK:Cre and Triple-Cre ablated mutants, which only differ by the
presence/absence of the EM subset, exhibited very similar
craniofacial defects at E12.5 but vastly differed regarding their
forebrain phenotype. This allowed us, therefore, to dissociate
forebrain formation and facial morphogenesis, and demonstrate
that these two processes rely on distinct players, namely ‘‘early’’
(2–4ss) and ‘‘late’’ (from 5–6ss) dbx1-expressing subsets respective-
ly. Since all targeted ablations resulted in different craniofacial
phenotypes, and none of them recapitulated the defects observed
in PGK:Cre or Triple-Cre ablated mutants, our results show that
each dbx1-expressing population has a specific role and that their
coordinated activity is required to ensure accurate facial
morphogenesis. Importantly, the dDM, vDi and ANR/FE dbx1-
expressing subsets largely overlap with region producing Wnts/
BMPs, Shh and Fgf8 respectively. Given the key function of these
molecules in both craniofacial morphogenesis and forebrain
patterning [31–34], they appear as good candidates to have a
significant contribution to the ablation phenotype.
Non cell-autonomous function of dbx1-derived cells
Apoptosis in PGK:Cre;Dbx1DTA embryos was observed from early
somite stages, prior to the onset of vasculogenesis or the initiation
Figure 7. Consequences of targeted ablations at E12.5. Heads of wild-type (A), Nkx2.1:Cre;Dbx1DTA (B), Foxg1Cre;Dbx1DTA (C) and
Wnt1:Cre;Dbx1DTA (D) E12.5 mouse embryos. (E–H) Nissl staining of coronal sections collected at the level of the eyes of the embryos shown in A–D.
Scale bars: 500 mm.
doi:10.1371/journal.pone.0019367.g007
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of neural tube closure, indicating that none of these processes can
account for increased cell death. Conversely, the failure of neural
tube closure could arise from increased apoptosis as it is observed
in several exencephalic mouse mutants [35]. The specific
enrichment of apoptotic cells observed at the lateral borders of
the neural plate of PGK:Cre;Dbx1DTA embryos could thus preclude
fusion of the neural folds. However, the failure of forebrain
maintenance in these mutants cannot be attributed to the neural
tube closure defect since Wnt1:Cre;Dbx1DTA embryos, which also
display an opened brain at E9.5 (data not shown), form a
forebrain.
Apoptosis in PGK:Cre;Dbx1DTA embryos was observed in regions
that neither express dbx1 nor derive from dbx1-expressing cells and
dbx1 expression was not upregulated upon ablation suggesting that
apoptosis in non cell-autonomous. We unambiguously demon-
strated that cell death is indeed non cell-autonomous using
targeted ablation in the presence of the R26YFP reporter allele, thus
allowing us to show that a large number of apoptotic cells are not
recombined in Foxg1Cre and Wnt1:Cre ablated mutants, and
therefore cannot undergo cell death because of DTA expression.
In addition to increased apoptosis, PGK:Cre;Dbx1DTA embryos also
displayed a reduction in the proliferation within the neural plate.
However, given the respective extent of the proliferation and
apoptosis defects in PGK:Cre;Dbx1DTA embryos, we believe that the
phenotype observed upon ablation mainly result from increased
cell death.
We have recently shown that other later-born Dbx1-derived
populations, generated between E10.5 and E12.5 and migrating
over long distances to settle in the cerebral cortex, regulate
proliferation and differentiation in a non cell-autonomous manner,
but were not involved in regulating cell survival [17,18]. We now
bring evidence that the earliest-born Dbx1-derived cells also share
the capacity to influence territories at distance from their
generation site but they have a unique role in cell survival. The
ability to regulate the development of adjacent tissues therefore
appears to be a common feature among Dbx1-derived cells.
Role of CNCCs during forebrain development
We have shown that the EM dbx1-expressing subset gives rise to
a specific subpopulation of CNCCs and we have correlated the
ablation of this subset with extensive apoptosis in surrounding
tissues and failure in forebrain formation. Tracing experiments
indicated that CNCCs are not the only progeny of the EM subset,
as some EM-derived cells remain in the neural plate where they
later intermingle with cells deriving from the dDM subset. Since
tracing of the Dbx1 lineage and ablation are mutually exclusive
strategies, it is not possible to precisely say which cells belonging to
the EM subset are spared in Triple-Cre;Dbx1DTA mutants. However,
the fact that (i) the Wnt1:Cre line drives recombination in all NCCs,
(ii) apoptotic cells in 4ss Triple-Cre;Dbx1DTA mutants are mostly
found in lateral regions, whereas (iii) untargeted dbx1+ cells are
more medial, suggest that Dbx1-derived CNCCs are likely to be
ablated in Triple-Cre;Dbx1DTA mutants. This is also supported by
the small reduction in sox10 staining observed at 4ss following
ablation with the Triple-Cre line, which matches the relatively small
number of Dbx1-derived CNCCs found in wild-types. By contrast,
the strong decrease in sox10 staining observed in PGK:Cre;Dbx1DTA
embryos suggests that a significant number of CNCCs which are
not from the Dbx1 lineage undergo cell death in these mutants. It
is thus likely that dbx1-expressing cells belonging to the EM subset
control forebrain formation by regulating the production/survival
of CNCCs.
To date, little is known concerning the role of CNCCs during
forebrain development in mice. By contrast, this question was
Figure 8. Comparison between PGK:Cre and Triple-Cre driven
ablations. (A) Head of an E12.5 Triple-Cre;Dbx1DTA embryo. The red
arrowhead indicates the forebrain. (B) Nissl-stained coronal section of
an E12.5 Triple-Cre;Dbx1DTA embryo at the level of the eyes. (C–E) Dorsal
views of whole-mount in situ hybridisation for dbx1 on wild-type (C),
PGK:Cre;Dbx1DTA (D), Triple-Cre;Dbx1DTA (E) 4ss embryos. A significant
number of dbx1-expressing cells (arrows) appear to escape ablation in
Triple-Cre ablated embryos. The strong staining in D corresponds to the
(out of focus) rhombencephalic expression of dbx1, and appears
obvious because revelation time had to be increased in PGK:Cre ablated
embryos in order to visualise the very few positive cells that remain. (F–
H) Whole-mount TUNEL staining on wild-type (F), PGK:Cre;Dbx1DTA (G),
Triple-Cre;Dbx1DTA (H) 4ss embryos. I–K are sections of these embryos
collected at the levels indicated by dashed lines. Less apoptotic cells are
found in Triple-Cre than in PGK:Cre ablated embryos. (L–Q) Whole-
mount in situ hybridisation for sox10 on wild-type (L, O),
PGK:Cre;Dbx1DTA (M, P) and Triple-Cre;Dbx1DTA (N, Q) embryos at 4ss
(L–N) and 8ss (O–Q). At 4ss, PGK:Cre;Dbx1DTA embryos show a strong
decrease in the number of sox10+ premigratory CNCCs whereas Triple-
Cre;Dbx1DTA are less severely affected. At 8ss, very few sox10+ CNCCs
have invaded the cephalic mesenchyme in PGK:Cre;Dbx1DTA whereas
Triple-Cre;Dbx1DTA are not as severely affected. Scale bars: A, B: 500 mm;
C, O: 200 mm; I: 100 mm.
doi:10.1371/journal.pone.0019367.g008
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previously addressed using avian models. In chicken, surgical
excision of the neural folds generating facial skeletogenic CNCCs
prior to their delamination (2–5ss) results in the complete absence
of the telencephalon [12]. When the excision is performed at
slightly later stages (5–6ss), a forebrain is formed, although its
patterning is severely affected and dorsal midline closure does not
occur [10,13]. Subtle variations in the timing of the ablation
therefore have a profound influence on its outcome.
In our system, we mimic the consequences of a surgical removal
of the mid-diencephalic to anterior-rhombencephalic neural folds,
using genetic means to perform the ablation of only a very specific
and molecularly characterised population of cells. In addition, we
show that forebrain formation is maintained when some of the
earliest dbx1-expressing cells are spared from the ablation.
Increased apoptosis in PGK:Cre;Dbx1DTA embryos is observed
from early stages and is clearly the main cause to the phenotype
we observe. In chicken experiments, increased apoptosis was
observed in forebrain tissues, but it was reported 24 to 48 hours
after surgery and only in the case of 2–5ss ablations [10–13]. The
contribution of apoptosis in the avian paradigm of CNCCs
depletion thus remains to be precisely assessed in order to better
understand how CNCCs contribute to forebrain development.
Mechanisms of Dbx1-derived cells function
In PGK:Cre;Dbx1DTA embryos, anterior neural territories are
correctly induced but fail to be maintained and undergo extensive
apoptosis. One possible explanation of our observations is that
Dbx1-derived cells normally provide signals (whose identity
remains to be established) necessary for cell viability or cell
survival in surrounding tissues. Such a function could be fulfilled
by long-range diffusing molecules originating from the neural
tissue itself and/or by signals locally released by migrating
CNCCs. Further studies will be required in order to discriminate
between these two hypotheses. Of note, although the function of
the dbx1 gene is not precisely known during forebrain develop-
ment, Dbx1 itself is most likely not involved in the processes we
describe here as dbx1-deficient embryos form a forebrain and do
not display defects in craniofacial morphogenesis ([25] and
unpublished results).
A large number of mouse mutants displaying aberrant head
morphogenesis have been identified [36], but in most instances the
defects result from improper induction or patterning rather than
increased cell death as it is the case in PGK:Cre;Dbx1DTA. A specific
feature of our model is the fact that the eye fields remain
unaffected despite extensive apoptosis in neighbouring areas,
suggesting that the signalling partners mediating the survival of
presumptive forebrain tissues are different from those involved in
eye development.
All thing considered, the model that best recapitulates the
phenotype of PGK:Cre;Dbx1DTA mutants is probably the CNCC
ablation paradigm in chick [10,12,13]. However, although a
mechanism involving BMP antagonists was proposed to mediate
CNCCs function [11], the fact that it relies on the control of
neural tube closure, forebrain growth and patterning but not on
the regulation of survival suggests significant divergence between
our respective systems.
In this study, we identify novel dbx1-expressing populations at
early stages of neural development and demonstrate that, despite
their limited number, they exert a critical function in maintaining
forebrain and craniofacial development. In gastrulating zebrafish
embryos, the ablation of only a dozen of anterior ectodermal cells
was shown to result in major brain patterning defects followed by
widespread apoptosis [37]. In mice, early dbx1-expressing cells
constitute a unique example of such few cells having a crucial
function during brain development.
Supporting Information
Figure S1 Nestin:Cre driven ablation of Dbx1-derived
cells at E12.5. Heads of wild-type (A) and Nestin:Cre;Dbx1DTA (B)
E12.5 mouse embryos. The obvious reduction in the size of the
midbrain in mutants is indicated by the yellow arrowhead in B.
(C–D) Coronal sections collected at the level of the eyes of wild-
type (C) and Nestin:Cre;Dbx1DTA (D) E12.5 mouse embryos. The red
arrowhead in D points at the reduction in the thickness of the
medial ganglionic eminence in mutants. Scale bars: A, C: 500 mm.
(TIF)
Figure S2 Morphological defects in E8.5 PGK:Cre;Dbx1DTA
embryos. (A) Quantification of the width of the neural plate at
the level of the midbrain in 2–4ss control and PGK:Cre;Dbx1DTA
embryos. (B) Quantification of the length between the pre-otic
sulcus and the anterior limit of the forebrain in 3 to 8ss control
and PGK:Cre;Dbx1DTA embryos. * p,0.001. (C) In situ hybridisa-
tion for dbx1 on 6ss control and ablated mutants. (D) TUNEL
staining of presomitic E8.0 embryos showing the normal levels of
apoptosis in mutants. Embryos are shown from above (anterior is
up); the red asterisk indicates the node. (E) Sections collected at
the level of the spinal cord of 3ss control and PGK:Cre;Dbx1DTA
embryos stained by TUNEL. Scale bars: C: 200 mm; D: 50 mm.
(TIF)
Figure S3 Targeted ablation of the Dbx1-expressing
subsets. The Nkx2.1:Cre line drives recombination in a domain
(arrow in A) overlapping with the vDi subset (arrow in B) and
allows its ablation (C, D). The Wnt1:Cre line drives recombination
in the dDM region (arrows in E, F) and allows the complete
ablation of the dbx1-expressing cells in this area (G, H). Using, the
Foxg1Cre line, recombination occurs in the facial ectoderm
(arrowhead in I) and anterior forebrain (arrow in I) but also in a
salt and pepper manner along the neural tube and mesenchyme
(J). Ablation driven by the Foxg1Cre line does not significantly affect
the vDi and dDM subsets (K, L). At 6ss, both the Foxg1Cre (M) and
Wnt1:Cre (N) lines allow recombination in the mesencephalic
neural plate (arrows in M and N). The Wnt1:Cre line also drive
recombination in CNCCs (arrowhead in E and N). (O–P) Whole-
mount in situ hybridisation for dbx1 in control (O) and
Foxg1Cre;Dbx1DTA (P) 14ss embryos. Arrows in O and P as well as
sections (Q and S) indicate the effective ablation of the ANR subset
in Foxg1Cre;Dbx1DTA embryos. Arrowheads in O and P as well as
sections (R and T) show that the FE subset is efficiently ablated in
Foxg1Cre;Dbx1DTA embryos. Scale bars: A: 100 mm; C, O: 200 mm;
Q: 50 mm.
(TIF)
Figure S4 Quantification of cell-autonomous and non
cell-autonomous apoptosis. Counting of the number of YFP
positive/negative cells among Caspase-3+ cells in FoxG1Cre;R26-
YFP;Dbx1DTA and Wnt1:Cre;R26YFP;Dbx1DTA embryos. Most apo-
ptotic cells located within the recombination domain (grey) were
YFP+ (29/41 in the telencephalon of FoxG1Cre;R26YFP;Dbx1DTA and
116/169 in the mesencephalon and diencephalon of
Wnt1:Cre;R26YFP;Dbx1DTA embryos). On the contrary, most
Caspase-3+ cells found in the mesencephalon and diencephalon
of FoxG1Cre;R26YFP;Dbx1DTA or in the telencephalon of
Wnt1:Cre;R26YFP;Dbx1DTA embryos were YFP2 (163/185 and
69/81 respectively), ruling out the possibility that these cells died
because of DTA expression.
(TIF)
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Figure S5 Patterning defects in Wnt1:Cre ablated
embryos. Side (A, C) and front (B, D) views of foxg1 expression
in control (A, B) and Wnt1:Cre;Dbx1DTA (C, D) 8ss embryos. The
arrows in C and D point to the dorsal and medial expansion of the
expression domain respectively. Side (E, G) and top (F, H) views of
emx2 expression in control (E, F) and Wnt1:Cre;Dbx1DTA (G, H) 9ss
embryos. Ablated mutants display a posterior shift in the dorsal
limit of emx2 expression (arrows). Scale bar: 200 mm.
(TIF)
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